Clinical Trials Logo

Clinical Trial Summary

The aim of the study was to investigate the effectiveness of non-invasive auricular vagus nerve stimulation on pain and pulse variability in women aged 18-55 years with migraine. It is also aimed to see the effects of vagus nerve stimulation from all directions by making pain, pulse, blood pressure and autonomic measurements.


Clinical Trial Description

Migraine, a neurological disorder that causes severe disability, is characterized by recurrent moderate to severe attacks associated with vegetative symptoms. Patients with frequent attacks may overuse drugs, which can lead to migraine chronization and headache. In the last decade, neuromodulatory approaches have been developed for the treatment of headaches that do not respond adequately to treatment. Non-invasive neuromodulation techniques are an evolving field in migraine research and treatment. Non-invasive vagus nerve stimulation is one of the non-invasive neuromodulation techniques. Promising findings on vagus nerve stimulation in people with chronic pain, including migraine and cluster headaches, are slowly being recognized. Stimulation of the vagus nerve provides a way of regulating autonomic tone. Auricular vagus nerve stimulation regulates abnormal sympatho-vagal balance while activating the parasympathetic system, including anti-inflammatory pathways (cholinergic anti-inflammatory pathway and hypothalamic-pituitary adrenal axis). It is aimed to evaluate the effect on pain and pulse variability after vagus nerve stimulation in women with migraine disease and to learn how the vagus nerve crosses according to the pulse measurements taken from the right and left index fingers. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05748535
Study type Interventional
Source Bahçesehir University
Contact
Status Completed
Phase N/A
Start date June 6, 2022
Completion date January 27, 2023

See also
  Status Clinical Trial Phase
Terminated NCT04520425 - Osteopathic Manipulative Techniques for the Treatment of Chronic Migraine Headaches N/A
Recruiting NCT06247592 - Pulse Radiofrequency and Occipital Nerve Block for Chronic Migraine Patients N/A
Recruiting NCT06133491 - Open Label, 6-month Study for High Frequency and Chronic Migraine,
Recruiting NCT04989413 - Cannabidiol 133mg + Cannabigerol 66mg + Tetrahydrocannabinol 4mg vs Placebo as Adjuvant Treatment in Chronic Migraine - Phase 4
Recruiting NCT06138171 - Personality, Defences, Central Sensitization, and Trauma in Women With Chronic Migraine, Fibromyalgia, and Vulvodynia
Active, not recruiting NCT06109389 - The Efficacy Of Lidocaine Infusion IN Chronic Unilateral Migraine Headache Phase 2
Completed NCT04871581 - Adjunctive Treatment of Chronic Migraine Using an Oral Dental Device N/A
Withdrawn NCT01749423 - A Retrospective Study to Evaluate the Effectiveness of onabotulinumtoxinA in Preventing Headaches in Patients With Chronic Migraines N/A
Terminated NCT04349176 - Onabotulinum Dose Comparison in Chronic Migraine Superior to 100 Units? Phase 3
Completed NCT05381129 - The Effect of Accompanying Temporomandibular Joint Dysfunction in Patients With Chronic Migraine N/A
Completed NCT05381012 - Fibromyalgia Syndrome on Patients With Chronic Migraine N/A
Withdrawn NCT03465826 - Developing a Mobile Health Pain-Coping Skills Training Program for the Treatment of Chronic Migraine: AIM 4 N/A
Completed NCT03767062 - Peripheral Nerve Block and Topiramate in the Treatment of Medication Overuse Headaches N/A
Recruiting NCT05724771 - COACT Study: CGRPmAbs + OnabotulinumtoxinA Assessment of Chronic Migraine Treatments Study Phase 4
Recruiting NCT05313503 - KETOMIGRAINE: Ketogenic Diet in Drug-resistant Chronic Migraineurs N/A
Recruiting NCT05079659 - Rate , Predictors and Outcome of Chronic Migraine
Completed NCT03698409 - Onabotulinumtoxin Type A Reconstitution With Preserved Versus Preservative-free Saline in Chronic Migraine. Phase 4
Completed NCT06118190 - Mesotherapy in the Treatment of Chronic Migraine N/A
Completed NCT04017741 - A Study Investigating the Efficacy of GON Blocks. Phase 4
Completed NCT05679908 - A Study to Evaluate the Efficacy and Safety of TNX-1900 in Patients With Chronic Migraine Phase 2